Stemtek Therapeutics on the newspaper “El Correo”   El Correo, Spanish newspaper, wrote about Stemtek Therapeutics and our product Cell2Sphere.
Stemtek Therapeutics has the pleasure to announce that next February 22nd and 23rd, our CEO Dr. Angel Garcia Martin will be in London attending the “3D Cell Culture” congress organized by the SMI Group. Where he will be able to meet industry and research leaders, who will also talk about the latest technologies, challenges, updates and uses of the 3D cell culture. Angel will be delighted to meet you in London, please contact
Cell2Sphere is a 3D cell culture kit created specifically for use in cancer stem-cell research, pharmaceutical drug development, and personalized medicine. Cell2Sphere frozen spheroid tissue culture samples increase the shelf life of today’s 3D cultures, enhancing the biological relevance of preclinical in vitro 3D culture efficacy assays. See the Source and the full article here. Lucha contra el cáncer con 3-D

An exciting year ahead

Message from the CEO - January 03, 2017

2016 has just come to an end.  It has undoubtedly been a good year for StemTek.  Early in the year we welcome our new shareholders (Seed Capital Bizkaia, BasqueFondo and Helenes Ventures) that teamed with us to fuel the growth of the company.  2016 saw the redesign of our webpage with new spaces for communication and showcasing our technology.  In the Fall we launched our first product to the market, Cell2Sphere, a revolutionary 3D cell culture kit enriched on cancer stem ...

Cancer Stem Cells Impact on Treatment, Obergurgl

By Angel Garcia Martin - December 16, 2016

Last week I attended the Cancer Stem Cells: Impact on Treatment conference in Obergurgl, Tyrol, Austria, getting the opportunity to interface with scientists from across the cancer stem cell field. It was a great conference where the top issues associated with this exciting topic came up for fruitful discussion in an unparalleled alpine environment.  I would like to thank and acknowledge the great work of the organizers, represented by Prof. Ira Skvortsova, Innsbruck Medical University. ...
Back to top